Yuyu Pharma, Inc. (000227.KS)
KRW 9750.0
(-0.41%)
KRW 9750.0
(-0.41%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -441.41 KRW | -65.38% |
| 2022 | -266.90 KRW | -362.81% |
| 2021 | -57.67 KRW | -129.67% |
| 2020 | 194.34 KRW | -48.56% |
| 2019 | 377.83 KRW | 34.22% |
| 2018 | 281.50 KRW | -30.67% |
| 2017 | 406.00 KRW | -17.73% |
| 2016 | 493.50 KRW | 2039.1% |
| 2015 | -25.45 KRW | 96.59% |
| 2014 | -746.43 KRW | -519.34% |
| 2013 | 178.00 KRW | -40.86% |
| 2012 | 301.00 KRW | 86.96% |
| 2011 | 161.00 KRW | 51.17% |
| 2010 | 106.50 KRW | -51.15% |
| 2009 | 218.00 KRW | 148.13% |
| 2008 | -452.98 KRW | -143.51% |
| 2007 | 1041.00 KRW | 59.54% |
| 2006 | 652.50 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 66.58 KRW | -81.82% |
| 2024 Q1 | 319.88 KRW | 576.44% |
| 2023 Q1 | 28.02 KRW | 125.53% |
| 2023 Q2 | -213.76 KRW | -862.88% |
| 2023 Q4 | -67.14 KRW | 59.94% |
| 2023 FY | - KRW | -65.38% |
| 2023 Q3 | -167.60 KRW | 21.59% |
| 2022 Q2 | -55.96 KRW | -1177.63% |
| 2022 FY | - KRW | -362.81% |
| 2022 Q4 | -109.75 KRW | -6.32% |
| 2022 Q1 | -4.38 KRW | 96.0% |
| 2022 Q3 | -103.23 KRW | -84.47% |
| 2021 FY | - KRW | -129.67% |
| 2021 Q1 | 27.00 KRW | 162.91% |
| 2021 Q2 | -14.00 KRW | -151.85% |
| 2021 Q3 | -41.00 KRW | -192.86% |
| 2021 Q4 | -109.48 KRW | -167.02% |
| 2020 Q1 | 177.50 KRW | 53.67% |
| 2020 Q3 | 53.00 KRW | 208.16% |
| 2020 Q4 | -42.92 KRW | -180.98% |
| 2020 FY | - KRW | -48.56% |
| 2020 Q2 | -49.00 KRW | -127.61% |
| 2019 Q1 | 101.00 KRW | 37.71% |
| 2019 Q2 | 88.00 KRW | -12.87% |
| 2019 FY | - KRW | 34.22% |
| 2019 Q4 | 115.51 KRW | 44.39% |
| 2019 Q3 | 80.00 KRW | -9.09% |
| 2018 Q1 | 134.00 KRW | 0.0% |
| 2018 FY | - KRW | -30.67% |
| 2018 Q2 | 68.00 KRW | -49.25% |
| 2018 Q4 | 73.34 KRW | 115.71% |
| 2018 Q3 | 34.00 KRW | -50.0% |
| 2017 Q3 | 151.50 KRW | 35.27% |
| 2017 Q1 | 147.04 KRW | 10.97% |
| 2017 FY | - KRW | -17.73% |
| 2017 Q2 | 112.00 KRW | -23.83% |
| 2016 Q4 | 132.50 KRW | -27.6% |
| 2016 Q1 | 5.19 KRW | -84.27% |
| 2016 FY | - KRW | 2039.1% |
| 2016 Q3 | 183.00 KRW | 889.19% |
| 2016 Q2 | 18.50 KRW | 256.45% |
| 2015 FY | - KRW | 96.59% |
| 2015 Q4 | 33.00 KRW | 175.0% |
| 2015 Q3 | -44.00 KRW | 50.0% |
| 2015 Q2 | -88.00 KRW | 88.1% |
| 2015 Q1 | -739.71 KRW | -1172.04% |
| 2014 Q3 | 71.00 KRW | 145.81% |
| 2014 FY | - KRW | -519.34% |
| 2014 Q4 | 69.00 KRW | -2.82% |
| 2014 Q1 | 110.65 KRW | 351.63% |
| 2014 Q2 | -155.00 KRW | -240.08% |
| 2013 Q4 | 24.50 KRW | 4.26% |
| 2013 Q1 | 221.58 KRW | 1242.91% |
| 2013 Q2 | 7.00 KRW | -96.84% |
| 2013 Q3 | 23.50 KRW | 235.71% |
| 2013 FY | - KRW | -40.86% |
| 2012 Q3 | 4.50 KRW | -75.0% |
| 2012 Q4 | 16.50 KRW | 266.67% |
| 2012 FY | - KRW | 86.96% |
| 2012 Q2 | 18.00 KRW | 118.37% |
| 2012 Q1 | -98.00 KRW | -212.0% |
| 2011 Q3 | 88.00 KRW | 114.63% |
| 2011 Q2 | 41.00 KRW | -65.47% |
| 2011 FY | - KRW | 51.17% |
| 2011 Q1 | 118.74 KRW | -32.15% |
| 2011 Q4 | 87.50 KRW | -0.57% |
| 2010 Q4 | 175.00 KRW | 181.35% |
| 2010 Q3 | -215.12 KRW | -1035.3% |
| 2010 Q2 | 23.00 KRW | -95.63% |
| 2010 Q1 | 526.08 KRW | 309.4% |
| 2010 FY | - KRW | -51.15% |
| 2009 Q4 | 128.50 KRW | 210.3% |
| 2009 Q3 | -116.50 KRW | 67.86% |
| 2009 Q1 | -476.57 KRW | -41.63% |
| 2009 Q2 | -362.50 KRW | 23.94% |
| 2009 FY | - KRW | 148.13% |
| 2008 Q1 | 33.32 KRW | -92.34% |
| 2008 FY | - KRW | -143.51% |
| 2008 Q4 | -336.50 KRW | -505.42% |
| 2008 Q3 | 83.00 KRW | -41.75% |
| 2008 Q2 | 142.50 KRW | 327.67% |
| 2007 FY | - KRW | 59.54% |
| 2007 Q2 | 623.60 KRW | 0.0% |
| 2007 Q3 | 164.00 KRW | -73.7% |
| 2007 Q4 | 435.22 KRW | 165.38% |
| 2006 FY | - KRW | 0.0% |